Skip to content

Bausch + Lomb BLCO Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
AbbVie logo
AbbVieABBV
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
Warby Parker logo
Warby ParkerWRBY
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.43B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's deferred tax assets and other non-current assets?
Bausch + Lomb (BLCO) reported deferred tax assets and other non-current assets of $302M in Q1 2026.
How has Bausch + Lomb's deferred tax assets and other non-current assets changed year-over-year?
Bausch + Lomb's deferred tax assets and other non-current assets increased by 2.4% year-over-year, from $295M to $302M.
What is the long-term trend for Bausch + Lomb's deferred tax assets and other non-current assets?
Over 4 years (2021 to 2025), Bausch + Lomb's deferred tax assets and other non-current assets has grown at a 14.6% compound annual growth rate (CAGR), from $180M to $310M.